R01 AG014452/AG/NIA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1999	1
2007	5
2008	5
2009	5
2010	2
2011	4
2012	5
2013	1
2014	1
2022	1
2024	0

1

Wolframin is a novel regulator of tau pathology and neurodegeneration.

Chen S, Acosta D, Li L, Liang J, Chang Y, Wang C, Fitzgerald J, Morrison C, Goulbourne CN, Nakano Y, Villegas NCH, Venkataraman L, Brown C, Serrano GE, Bell E, Wemlinger T, Wu M, Kokiko-Cochran ON, Popovich P, Flowers XE, Honig LS, Vonsattel JP, Scharre DW, Beach TG, Ma Q, Kuret J, Kõks S, Urano F, Duff KE, Fu H. Chen S, et al. Acta Neuropathol. 2022 May;143(5):547-569. doi: 10.1007/s00401-022-02417-4. Epub 2022 Apr 7. Acta Neuropathol. 2022. PMID: 35389045

2

Structure and mechanism of action of tau aggregation inhibitors.

Cisek K, Cooper GL, Huseby CJ, Kuret J. Cisek K, et al. Curr Alzheimer Res. 2014;11(10):918-27. doi: 10.2174/1567205011666141107150331. Curr Alzheimer Res. 2014. PMID: 25387336 Free PMC article. Review.

3

Modulation and detection of tau aggregation with small-molecule ligands.

Chang E, Honson NS, Bandyopadhyay B, Funk KE, Jensen JR, Kim S, Naphade S, Kuret J. Chang E, et al. Curr Alzheimer Res. 2009 Oct;6(5):409-14. doi: 10.2174/156720509789207976. Curr Alzheimer Res. 2009. PMID: 19874263 Free PMC article. Review.

4

Ligand electronic properties modulate tau filament binding site density.

Cisek K, Jensen JR, Honson NS, Schafer KN, Cooper GL, Kuret J. Cisek K, et al. Biophys Chem. 2012 Aug-Sep;170:25-33. doi: 10.1016/j.bpc.2012.09.001. Epub 2012 Sep 11. Biophys Chem. 2012. PMID: 23072817 Free PMC article.

5

Tau aggregation and toxicity in tauopathic neurodegenerative diseases.

Honson NS, Kuret J. Honson NS, et al. J Alzheimers Dis. 2008 Aug;14(4):417-22. doi: 10.3233/jad-2008-14409. J Alzheimers Dis. 2008. PMID: 18688092 Free PMC article. Review.

6

Progranulin expression is upregulated after spinal contusion in mice.

Naphade SB, Kigerl KA, Jakeman LB, Kostyk SK, Popovich PG, Kuret J. Naphade SB, et al. Acta Neuropathol. 2010 Jan;119(1):123-33. doi: 10.1007/s00401-009-0616-y. Epub 2009 Nov 28. Acta Neuropathol. 2010. PMID: 19946692 Free PMC article.

7

Structural determinants of Tau aggregation inhibitor potency.

Schafer KN, Cisek K, Huseby CJ, Chang E, Kuret J. Schafer KN, et al. J Biol Chem. 2013 Nov 8;288(45):32599-32611. doi: 10.1074/jbc.M113.503474. Epub 2013 Sep 26. J Biol Chem. 2013. PMID: 24072703 Free PMC article.

8

Structure-activity relationship of cyanine tau aggregation inhibitors.

Chang E, Congdon EE, Honson NS, Duff KE, Kuret J. Chang E, et al. J Med Chem. 2009 Jun 11;52(11):3539-47. doi: 10.1021/jm900116d. J Med Chem. 2009. PMID: 19432420 Free PMC article.

9

Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles.

Funk KE, Mrak RE, Kuret J. Funk KE, et al. Neuropathol Appl Neurobiol. 2011 Apr;37(3):295-306. doi: 10.1111/j.1365-2990.2010.01135.x. Neuropathol Appl Neurobiol. 2011. PMID: 20946470 Free PMC article.

10

Tau isoform composition influences rate and extent of filament formation.

Zhong Q, Congdon EE, Nagaraja HN, Kuret J. Zhong Q, et al. J Biol Chem. 2012 Jun 8;287(24):20711-9. doi: 10.1074/jbc.M112.364067. Epub 2012 Apr 26. J Biol Chem. 2012. PMID: 22539343 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year